Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
130,702,820
-
Total 13F shares
-
57,639,569
-
Share change
-
+2,518,842
-
Total reported value
-
$422,207,215
-
Put/Call ratio
-
132%
-
Price per share
-
$7.33
-
Number of holders
-
180
-
Value change
-
+$21,955,759
-
Number of buys
-
79
-
Number of sells
-
61
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q3 2024
As of 30 Sep 2024,
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by
180 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,639,569 shares.
The largest 10 holders included
BlackRock, Inc., ARMISTICE CAPITAL, LLC, TANG CAPITAL MANAGEMENT LLC, NEA Management Company, LLC, STATE STREET CORP, GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, MORGAN STANLEY, and Nuveen Asset Management, LLC.
This page lists
180
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.